Clinical Trials Directory

Trials / Completed

CompletedNCT03555279

PHAT Life: Peer Versus Adult-Led HIV Prevention for Juvenile Offenders

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
218 (actual)
Sponsor
University of Illinois at Chicago · Academic / Other
Sex
All
Age
13 Years – 17 Years
Healthy volunteers
Accepted

Summary

This application proposes a 2-arm randomized controlled trial comparing the impact of PHAT Life on 350 13-17 year-old offenders' risky sex, STI, substance use, and theoretical mediators when delivered by Youth Representatives (YR) vs. probation staff (PS). 100 facilitators will be recruited to deliver the intervention and participate in the research.

Detailed description

The main objectives of the proposed study are to compare the effectiveness, cost-effectiveness, and sustainability of Youth Representative-led vs. probation staff-led PHAT Life in a real-world juvenile probation setting. The Specific Aims of this study are: 1. To conduct a methodologically-rigorous 2-arm trial comparing the impact of PHAT Life on 350 13-17 year-old offenders' risky sex, STI, substance use, and theoretical mediators when delivered by Youth Representatives (YR) vs. probation staff (PS). 2. To compare the costs and cost-effectiveness of 100 YR-led vs. PS-led PHAT Life with respect to the acquisition of incident STI. We hypothesize: (a) Compared to teens in PS-led groups, we expect teens in YR-led groups to report less risky sex and substance use at 6-month follow-up, to demonstrate greater improvement on theoretical mediators of risk, and to have fewer incident STI infections; (b) We expect YR-led PHAT Life to cost less and be more cost-effective than PS-led PHAT Life.

Conditions

Interventions

TypeNameDescription
BEHAVIORALPHAT Life: Preventing HIV/AIDS Among Teens--PS ArmHIV Prevention Behavioral Health Intervention delivered by Probation Staff
BEHAVIORALPHAT Life: Preventing HIV/AIDS Among Teens--YR ArmHIV Prevention Behavioral Health Intervention delivered by Youth Representatives

Timeline

Start date
2017-03-13
Primary completion
2021-04-05
Completion
2021-05-26
First posted
2018-06-13
Last updated
2023-04-21

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03555279. Inclusion in this directory is not an endorsement.